Climate models predicted that the equatorial Pacific trade winds should weaken with increasing greenhouse gases, yet satellites and climate stations have instead revealed a rapid and unprecedented strengthening of the Pacific trade winds since the 1990s. 

Last week's Environmental Protection Agency (EPA) hearings in Atlanta on rules intended to "dramatically cut emissions" from coal-fired electricity generating stations were as contentious as expected. 

A new study commissioned by the National Association of Manufacturers (NAM) estimates that the Obama Administration's new ozone restrictions could reduce GDP by $270 billion per year and carry a compliance price tag of $2.2 trillion from 2017 to 2040 - the most expensive regulation the U.S. government has ever issued. 

In total, the study finds that letting the EPA revise the ozone standard for manufacturing from 75 parts per billion (ppb) to 60 ppb - below what even  exists at national parks, such as Yellowstone and Denali - could:

- Reduce U.S. GDP by $270 billion per year and $3.4 trillion from 2017 to 2040; 
- Result in 2.9 million fewer job equivalents per year on average through 2040; 

XBiotech has begun its European Phase III study using its novel cancer drug Xilonix™ for the treatment of colorectal cancer.

Xilonix is an antiobody works to block a number of processes that tumors use to grow and spread, such as potentially inhibiting the formation of tumor blood supply and new metastasis. Blocking tumor-related inflammation may also inhibit or reverse wasting and other illness associated with the malignancy. 

The double-blinded placebo controlled study is evaluating the use of the monoclonal antibody therapy designed to block chronic inflammation associated with malignant tumor growth. The treatment is reportedly aimed at reversing disease symptoms associated with disease progression and survival.

Shaving facial hair, bikini line, legs and armpits can cause wounds, which are an ideal setting for Staphylococcus aureus bacteria to cause infections. This 'shaving irritation' is characterized by redness, pimples, shaving bumps and an itching and burning sensation.

Antibiotics and traditional anti-bacterial products do not distinguish between good and bad bacteria but a healthy bacterial population is important. Dutch market research panel 'hettestpanel.nl' tested Gladskin Skin Irritation on a large group of men and women suffering from skin irritation after shaving and it received an 80% score on efficacy and 91% on user satisfaction.  

Results  presented at the 2014 World Transplant Congress evaluated the safety and efficacy of CSL Behring's C1 Inhibitor (C1-INH) concentrate in preventing antibody-mediated rejection following kidney transplants in highly sensitized patients.

C1-INH is a human protein and an important inhibitor of the complement system. Antibody-mediated rejection is a major cause of kidney transplant failure and a prime barrier to improving long-term outcomes for transplant patients. The types of antibody-mediated rejection vary in acuity and severity. Approximately 10 to 15 percent of kidney recipients experience rejection within one year after transplantation.